Prelude Capital Management’s Verastem VSTM Stock Holding History

Prelude Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$767K	Buy	144,719 +70,498	+95%	+$435K	0.06%	360
2025 Q4	$573K	Buy	+74,221	New	+$661K	0.04%	479
2025 Q3	–	Sell	-180,400	Closed	-$749K	–	1407
2025 Q2	$749K	Buy	+180,400	New	+$1.13M	0.07%	333
2017 Q4	–	Sell	-375	Closed	-$21K	–	1748
2017 Q3	$21K	Buy	375 +125	+50%	+$5.9K	﹤0.01%	1313
2017 Q2	$7K	Sell	250 -2,167	-90%	-$55.1K	﹤0.01%	1444
2017 Q1	$60K	Buy	2,417 +784	+48%	+$12.4K	0.01%	921
2016 Q4	$22K	Buy	1,633 +1,025	+169%	+$15.3K	﹤0.01%	1299
2016 Q3	$10K	Buy	+608	New	+$9.79K	﹤0.01%	1433

Other funds holding VSTM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prelude Capital Management's VSTM Position: Q1 2026 in Review

Prelude Capital Management increased its Verastem (VSTM) stake by 95% in Q1 2026, buying an estimated $435K and bringing the position to 144,719 shares worth $767K. The position accounts for 0.06% of the portfolio, ranked #360.

Prelude Capital Management first reported a position in VSTM in Q3 2016 and has held it in 8 quarters since. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

Prelude Capital Management held 144,719 shares of Verastem worth $767K as of Q1 2026.
Prelude Capital Management bought 70,498 Verastem shares in Q1 2026, an estimated $435K.
Verastem made up 0.06% of Prelude Capital Management's portfolio in Q1 2026, its #360 holding.
Prelude Capital Management first reported a position in Verastem in Q3 2016 and has held it in 8 quarters since.
155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.